Catalyst Wire Dossier Catalyst Wire Dossier

ERY-TAB

erythromycin · Arbor Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ERY-TAB, covering 2006-05-18 to 2019-06-28. Get the full timeline:

Most recent: FDA Approved: ERY-TAB — Supplemental Application (Arbor Pharmaceuticals, Inc.)

See pricing